Lé, A. M., Yilmaz, O., Luz, M., & Torres, T. (2025). Oral roflumilast for psoriasis: A real-world 24-week prospective cohort study. Journal of Dermatological Treatment, 36(1), 1. https://doi.org/10.1080/09546634.2025.2464107
Chicago Style (17th ed.) CitationLé, Ana Maria, Orhan Yilmaz, Martim Luz, and Tiago Torres. "Oral Roflumilast for Psoriasis: A Real-world 24-week Prospective Cohort Study." Journal of Dermatological Treatment 36, no. 1 (2025): 1. https://doi.org/10.1080/09546634.2025.2464107.
MLA (9th ed.) CitationLé, Ana Maria, et al. "Oral Roflumilast for Psoriasis: A Real-world 24-week Prospective Cohort Study." Journal of Dermatological Treatment, vol. 36, no. 1, 2025, p. 1, https://doi.org/10.1080/09546634.2025.2464107.
Warning: These citations may not always be 100% accurate.
